Invus Global Management LLC 13D and 13G filings for Silence Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:31 pm Purchase | 2024-09-30 | 13G | Silence Therapeutics plc SLN | Invus Global Management LLC | 8,495,310 6.100% | 156,453 (+1.88%) | Filing |
| 2024-08-02 6:51 pm Purchase | 2024-07-25 | 13G | Silence Therapeutics plc SLN | Invus Global Management LLC | 8,338,857 6.000% | 8,338,857 (New Position) | Filing |